HAART Main Page

Medical Advocates
HAART/ART

Viral Dynamics

General Reports
Viral Rebound

HAART Main Page Main New/Newsworthy Home Page

Last Update: August 18, 2008
Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader

General Reports

Journal Papers, Abstracts, and Commentaries

Treatment response in acute/early infection versus advanced AIDS: equivalent first and second
phases of HIV RNA decline.
Kilby JM, Lee HY, Hazelwood JD, et al
AIDS. 2008 May 11;22(8):957-62.
Abstract

Psychiatric Illness and Virologic Response in Patients Initiating Highly Active Antiretroviral
Therapy.
Pence BW, Miller WC, Gaynes BN, Eron JJ Jr.
J Acquir Immune Defic Syndr. 2006 Nov 30;
Abstract

Rate of Viral Evolution and Risk of Losing Future Drug Options in Heavily Pretreated,
HIV-Infected Patients Who Continue to Receive a Stable, Partially Suppressive Treatment
Regimen.
Hatano H, Hunt P, Weidler J, et al
Clin Infect Dis. 2006 Nov 15;43(10):1329-36.
Abstract

Discordant immunological and virological responses to antiretroviral therapy.
Schechter M, Tuboi SH.
Antimicrob Chemother. 2006 Jul 19;
Abstract

A WEEK-IN-REVIEW FEATURED REPORT
Regional Changes Over Time in Initial Virologic Response Rates to Combination Antiretroviral
Therapy Across Europe.
Bannister WP, Kirk O, Gatell JM, et al
J Acquir Immune Defic Syndr. 2006 Jun;42(2):229-237.
Abstract

Factors Associated with Poor Immunologic Response to Virologic Suppression by Highly
Active Antiretroviral Therapy in HIV-Infected Women.
Vaamonde CM, Hoover DR, Anastos K, et al
AIDS Res Hum Retroviruses. 2006 Mar;22(3):222-31.
Abstract

A WEEK-IN-REVIEW FEATURED REPORT
FULL-TEXT ARTICLE
Viral Load Responses to HAART is an Independent Predictor of a New AIDS Event in Late Stage
HIV Infected Patients: Prospective Cohort Study.
Kazanjian P, Amin K, Brown M, Wei W.
J Transl Med. 2005 Oct 31;3(1):40 [
PDF Paper

An improvement in virologic response to highly active antiretroviral therapy in clinical practice from
1996 through 2002.
Moore RD, Keruly JC, Gebo KA, Lucas GM.
J Acquir Immune Defic Syndr. 2005 Jun 1;39(2):195-8.
Abstract

Time to Virological Failure of 3 Classes of Antiretrovirals after Initiation of Highly Active
Antiretroviral Therapy: Results from the EuroSIDA Study Group.
Mocroft A, Ledergerber B, Viard JP, et al.
J Infect Dis. 2004 Dec 1;190(11):1947-1956.
Abstract

Long-Term CD4+ T-Cell Response to Highly Active Antiretroviral Therapy According to
Baseline CD4+ T-Cell Count.
Garcia F, De Lazzari E, Plana M, et al J
Acquir Immune Defic Syndr. 2004 Jun 1;36(2):702-713.
Abstract

Long-term virological response to multiple sequential regimens of highly active
antiretroviral therapy for HIV infection.
Kaufmann GR, Khanna N, Weber R, et al
Antivir Ther. 2004 Apr;9(2):263-74.
Abstract

CD4 T cell recovery is slower in patients experiencing viral load rebounds during
HAART.
Scott-Algara D, Aboulker JP, Durier C, et al.
Clin Exp Immunol 2001 Nov;126(2):295-303
Abstract

HIV viral load response to antiretroviral therapy according to the baseline CD4
cell count and viral load.
Phillips AN, Staszewski S, Weber R, et al
JAMA. 2001 Nov 28;286(20):2560-7.
Abstract

Conference Reports, Abstracts, and Posters

POWERPOINT POSTER PRESENTATION
Virologic response to HAART among incarcerated HIV+ individuals
D Wohl
(XVII International AIDS Conference)
Poster Presentation

Treatment History but not Previous Genotype Improves the Accuracy of Predicting Virologic
Response to HIV Therapy
B. LARDER, D. WANG, A. REVELL , et al
(46 ICAAC)
Abstract

Durability of HAART Regimens over Time
(41 ICAAC)
Abstract

Viral Rebound

Journal Papers, Abstracts, and Commentaries

Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1
patients: a prospective cohort study. Swiss HIV Cohort Study.
Ledergerber B, Egger M, Opravil M, et al.
Lancet. 1999 Mar 13;353(9156):863-8.
Abstract

	Virological rebound after suppression on highly active antiretroviral therapy. Mocroft A, Ruiz L, Reiss P AIDS. 2003 Aug 15;17(12):1741-1751. Abstract
	Consecutive rebounds in plasma viral load are associated with virological failure at 52 weeks among HIV-infected patients. Raboud JM, Rae S, Woods R, et al AIDS. 2002 Aug 16;16(12):1627-32. Abstract
	Raised viral load in patients with viral suppression on highly active antiretroviral therapy: transient increase or treatment failure? Moore AL, Youle M, Lipman M, et al. AIDS. 2002 Mar 8;16(4):615-8. Abstract

HAART Main Page Main New/Newsworthy Home Page

HAART/ART Viral Dynamics